News
Contact us on comms@oxfordsp.com if you would like to know more about any of these stories, or The Oxford Science Park. You can also follow us on twitter @OxfordSciencePK
2021
8th April 2021
Oxford Endovascular raises $10m to develop origami engineered device to prevent brain haemorrhage
Funding will support the company to achieve first-in-human data Oxford, UK, 8th April 2021 -…
17th March 2021
Vaccitech Completes $168M Series B Financing to Advance 3 Clinical Programs Through Phase 2 Results
Oxford, UK – Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical company engaged in the discovery and development…
2nd March 2021
WuXi AppTec Completes Acquisition of OXGENE to Strengthen Cell & Gene Therapy Service Offerings
WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings…
18th February 2021
Evox Therapeutics completes £69.2 million Series C financing
18th Feb 2021 Financing round significantly oversubscribed by both new and existing investors Proceeds enable…
11th February 2021
Exscientia & University of Oxford announce partnership to develop treatments for Alzheimer’s disease
Neuroinflammation collaboration targeting inflammasome steps-up-the-pace in race for Alzheimer’s disease medicines that alleviate the burden…
5th February 2021
Immunocore Announces Pricing of Upsized Initial Public Offering
Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel…
1st February 2021
Vaccitech Doses 1st Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP300 immunotherapeutic candidate for Chronic HBV
Oxford, UK – 1st February 2021 – Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in…
29th January 2021
Mobile laboratories use LamPORE COVID-19 test, UK Government LamPORE evaluation report shows high accuracy
Mobile COVID-19 testing laboratories containing Oxford Nanopore’s LamPORE test are now being deployed in a…
12th January 2021
Boehringer Ingelheim & Enara Bio enter Strategic Collaboration & Licensing Agreement to discover novel shared antigens for cancer immunotherapies
Ingelheim, Germany and Oxford and London, UK, January 12th, 2021 – Boehringer Ingelheim and Enara Bio,…
12th January 2021
OXGENE introduces SLIM platform for discovery of antibodies against membrane proteins
Novel self-labelling mammalian display method for identifying antibodies against membrane proteins in their native configuration…
11th January 2021
Immunocore announces closing of $75.0 Million Series C round
Funding follows positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic…
4th January 2021
Exscientia launches Miami Office to recruit US-based Technology talent as part of continued expansion
Exscientia, the world-leading artificial intelligence (AI) driven Pharmatech company, today announces the opening of its US based Miami…
2020
30th December 2020
Oxford University & Vaccitech welcome UK regulatory emergency use authorisation of coronavirus vaccine
Oxford, UK – Vaccitech Ltd announces that the UK Government has today accepted the recommendation from the Medicines and Healthcare…
9th December 2020
Enara Bio relocates to The Oxford Science Park’s newest facility to expand R&D capabilities in the search for novel cancer immunotherapies
Oxford and London, UK – 9th December 2020. Enara Bio, a biotechnology company leveraging its…
8th September 2020
Innovate UK backs ATDBio & University of Oxford research in single-cell sequencing
New approach expected to increase use of technique in research and diagnosis Oxford, UK, September…
3rd August 2020
Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test
Mon 3rd August 2020 Ground-breaking British technology will initially provide hundreds of thousands of fast,…
29th July 2020
Innovate UK grant to further development of OrthoSon ultrasound technology in back pain
Innovate UK grant to further development of ultrasound technology in back pain Data from extended…
6th July 2020
Practical completion achieved for Bellhouse Building
Practical completion achieved for Bellhouse Building First tenants to move in to TOSP’s newest building…
9th June 2020
EVOX THERAPEUTICS ANNOUNCES MULTI-TARGET RNA INTERFERENCE & ANTISENSE RESEARCH COLLABORATION/LICENSE AGREEMENT WITH LILLY
Evox to use its proprietary exosome loading and CNS-targeting technologies to develop oligonucleotide drugs for…
24th April 2020
Scancell Holdings – Development of vaccine against COVID-19
24 April 2020 Scancell Holdings plc (“Scancell” or the “Company”) Scancell to initiate development of…
31st March 2020
Exscientia – joint initiative to identify COVID-19 drugs with Diamond Light Source & Scripps Research
Exscientia announces joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps Research…
2nd March 2020
Immunocore Secures $130 Million Series B Financing
Led by General Atlantic, funding will expand novel scientific platform and advance proprietary pipeline of…
30th January 2020
Sumitomo Dainippon Pharma & Exscientia – New Drug Candidate Created Using AI begins Clinical Trial
January 30, 2020 Sumitomo Dainippon Pharma Co., Ltd. Exscientia Ltd Sumitomo Dainippon Pharma and Exscientia…
9th January 2020
Bayer & Exscientia collaborate to leverage potential of AI in cardiovascular & oncology drug discovery
Exscientia, the leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered…
2019
5th December 2019
Green light for planning permission at Plot 16 as TOSP continues ambitious expansion plans
Green light for planning permission at Plot 16 as The Oxford Science Park continues ambitious…
15th October 2019
World renowned neuroscientist & mathematician recognised as TOSP’s Magdalen Centre is given new identity
Sherrington and Whitehead Buildings combine with new Bellhouse Building in 100,000…
4th September 2019
Intuitive Announces New UK Headquarters in Oxford
OXFORD, England--Intuitive (Nasdaq: ISRG), a global leader in minimally invasive care and the pioneer of…
6th March 2019
Blue Earth Diagnostics celebrates five year anniversary
Oxford, UK – March 6, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company,…
5th March 2019
Oxford Bus Company and the Oxford Science Park form partnership as part of joint drive to improve connectivity
OXFORD BUS COMPANY AND THE OXFORD SCIENCE PARK FORM PARTNERSHIP AS PART OF JOINT DRIVE…
4th March 2019
Vaccitech Awarded BARDA contract valued at $8.5M to conduct Phase II trial for Influenza Vaccine
Oxford, UK – 4 March 2019 Vaccitech announced today that it has been awarded a…
14th February 2019
First production and administration of Axumin (fluciclovine (18F)) in Italy
Oxford, UK – February 12, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company,…
2018
12th December 2018
First production and administration of Axumin (fluciclovine (18F)) in France
First production and administration of Axumin (fluciclovine (18F)) in France. Oxford, UK – December 12,…
1st November 2018
Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park
Facilities in The Schrödinger Building to bring together AI experts and biologists. Oxford, UK, 1…
12th October 2018
Blue Earth Diagnostics wins prestigious ‘Best Emerging Biotech’ award
Oxford, UK – October 12, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, has…
9th August 2018
Blue Earth Diagnostics shortlisted for prestigious ‘Best Emerging Biotech Company’ award
Oxford, UK – August 9, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, yesterday…
3rd August 2018
South Oxfordshire Science Village steams ahead
Plans for the South Oxford Science Village, a mixed community of high tech business space,…
5th July 2018
Minister of State Sam Gyimah MP to open Schrödinger Building at The Oxford Science Park
New building part of ongoing investment in development of Park Oxford, UK, July 5 2018 –…
19th April 2018
Driven by rapid growth Oxford Sciences Innovation expands to The Oxford Science Park
Thursday 19th April 2018 OSI builds on links with Park as second occupier of prestigious…
13th April 2018
Blue Earth Diagnostics opens new headquarters in Oxford
Friday 13th April 2018 Blue Earth Diagnostics opens new headquarters in Oxford Expanded facility positions…
19th March 2018
Fuel3D to establish new headquarters on The Oxford Science Park
Monday 19th March 2018 Company to be first occupier of the Park’s state-of-the-art Schrödinger Building…
9th March 2018
New Magdalen Centre – Planning Permission Granted
Friday 9th March 2018 8th March 2018 – The Oxford Science Park is pleased that Oxford City…
24th January 2018
Are you the most innovative company in Oxfordshire? Apply now for The Oxford Science Park Innovation Award, part of OXBA 2018
Wednesday 24th January 2018 Oxford, UK, 24th January 2018 – Oxfordshire companies which have progressed valuable innovations…
2017
11th December 2017
Leading biotech Immunocore expands to The Oxford Science Park
Monday 11th December 2017 Leading biotech Immunocore expands to The Oxford Science Park Oxford, UK,…
21st June 2017
Watch: The Schrödinger Building’s time lapse video
Wednesday 21st June 2017 With construction underway of The Schrödinger Building, our £13 million new…
2nd June 2017
Driving into the future as the Park is simulated
Friday 2nd June 2017 The Oxford Science Park is the first science, technology and…
27th March 2017
New kit for The Oxford Science Park’s netball club
Tuesday 7th March 2017 An Oxford netball club was treated to new team kit thanks…
8th February 2017
Contractor appointed for £13 million landmark Oxford scheme
Wednesday 8th February 2017 The Oxford Science Park has awarded a £13 million design and…
23rd January 2017
Childcare Minister visits to officially open new day nursery
Monday 23rd January 2017 The children and staff of Oxford’s newest day nursery were treated…
2016
8th December 2016
Plot 12 planning application approved
Thursday 8th December 2016 Response statement following Oxford City Council’s East Area Planning Committee meeting…
22nd November 2016
The Old Station Nursery makes it five with £100k refurbishment at The Oxford Science Park
Tuesday 22nd November 2016 The Old Station Nursery, an established family run childcare business, will…
19th October 2016
Fast growing UK synthetic biotech moves to The Oxford Science Park
Wednesday 19th October 2016 Oxford Genetics Ltd, a leading biotech which specialises in DNA…
15th August 2016
The Oxford Science Park submits new speculative office building designs to accommodate nearly 500 people
Monday 15th August 2016 The Oxford Science Park (the Park) has set out its new…
1st July 2016
Thrilling lunch break! Fun at the fair as 1,200+ people enjoy Summer Party at Science Park
Friday 1st July 2016 More than 1,200 people who work at The Oxford Science Park…
20th June 2016
Oxford Space Systems Scoops Innovation Award!
Monday 20th June 2016 Congratulations to Oxford Space Systems which scooped the Innovation Award, sponsored by The…
10th March 2016
Watch our New Park video!
Thursday 10th March 2016 The Oxford Science Park unveiled its striking new brand identity at…
5th January 2016
Magdalen College acquires 100% of The Oxford Science Park
Tuesday 5th January 2016 Magdalen College has completed the acquisition of the 50% stake in…
Careers
Check in here regularly if you are looking for an exciting new role at one of the companies on The Oxford Science Park.
LABORATORY & FACILITIES SERVICES MANAGER
There is further information on this role here https://www.jobs.ac.uk/job/CFB395/laboratory-and-facilities-services-manager
Closing date: April 19
IT DIRECTOR
There is further information on this role here https://enarabio.com/careers/it-director
Closing date: Open until filled
DIRECTOR OF BIOLOGY
There is further information on this role here https://enarabio.com/careers/director-of-biology
Closing date: Open until filled
(SENIOR) SCIENTIST – ANALYTICAL DEVELOPMENT
There is further information on this role here https://enarabio.com/careers/senior-scientist-analytical-development
Closing date: Open until filled
(SENIOR) SCIENTIST – CELL PROCESS DEVELOPMENT
There is further information on this role here https://enarabio.com/careers/senior-scientist-cell-process-development
Closing date: Open until filled
PRINCIPAL SCIENTIST, MASS SPECTROMETRY-BASED METABOLOMICS
There is further information on this role here https://enarabio.com/careers/principal-scientist-mass-spectrometry-based-metabolomics
Closing date: Open until filled
MEMBRANE PROTEIN SCIENTIST
There is further information on this role here Orbit Discovery Membrane Protein Scientist
Closing date: April 30 2021
SENIOR RESEARCH ASSISTANT/SCIENTIST – CELL LINE DEVELOPMENT
There is further information on this role here Orbit Discovery Senior-RA-Scientist – Cell line development
Closing date: April 30 2021
SENIOR RESEARCH ASSISTANT/RESEARCH SCIENTIST – PLATFORM DEVELOPMENT
There is further information on this role here Scientist – RA – Platform development 2021
Closing date: May 31 2021
SCIENTIST/RESEARCH SCIENTIST–
IMMUNOLOGY – PRIMARY CELL ASSAY DEVELOPMENT
There is further information on this role here JD Sitryx RESEARCH SCIENTIST02